Welcome to our dedicated page for Bio Green Med Solution SEC filings (Ticker: BGMS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Bio Green Med Solution, Inc. filings document the company's fire safety protection and distribution business, its completed shift from the former Cyclacel Pharmaceuticals biopharmaceutical operations, and its public-company governance. Regulatory reports include 8-K disclosures for quarterly and annual results, Regulation FD releases, material agreements, warrant exchanges, and preferred-stock dividend declarations.
The filing record also covers the company's common stock and 6% Convertible Exchangeable Preferred Stock, proxy materials for annual stockholder matters, Nasdaq listing-compliance matters involving the preferred stock, and corporate history items such as the acquisition of Fitters Sdn. Bhd., the liquidation of the former U.K. subsidiary, and the sale of Plogosertib.
Bio Green Med Solution (BGMS) disclosed an insider transaction on a Form 4. On October 30, 2025, a 10% owner sold 248,814 shares of common stock (Transaction Code S) at $1.8 per share. After the sale, the reporting person held 0 shares directly.
Bio Green Med Solution (BGMS) insider transaction: A reporting person filed a Form 4 showing a sale of common stock. On 10/29/2025, the insider sold 110,749 shares of BGMS common stock at a price of $1.834 per share. Following the transaction, the filer beneficially owned 140,760 shares, held as Direct (D) ownership.
The filing indicates it was submitted by one reporting person and relates to non-derivative securities only; no derivative transactions were reported. The issuer is Bio Green Med Solution, Inc. (BGMS).
Bio Green Med Solution (BGMS) insider activity: Yap Kim Choy, a director and 10% owner, reported a sale of 13,111 shares of common stock on 10/28/2025 at $1.828 per share (transaction code S). Following the transaction, he beneficially owned 251,509 shares, held directly. This update was disclosed on Form 4.
Bio Green Med Solution (BGMS) insider filing reports that director and 10% owner Yap Kim Choy sold 120,250 shares of common stock at $2.118 on 10/27/2025.
Following the sale, the filing shows 264,620 shares beneficially owned with direct ownership.
Bio Green Med Solution (BGMS) reported a Form 4 insider transaction showing a sale of 19,858 shares of common stock at $1.99 on October 24, 2025 (transaction code S).
Following the sale, the reporting person beneficially owned 248,814 shares, held directly.
Bio Green Med Solution (BGMS) insider Yap Kim Choy reported a sale of common stock on 10/24/2025 under transaction code S (sale). The filing shows 19,595 shares disposed at a price of $1.902 per share.
After this transaction, the reporting person beneficially owns 384,870 shares, held directly. The filer is listed as a 10% owner.
Bio Green Med Solution (BGMS) reported insider activity on Form 4. Director Datuk Tan Chor How Christopher sold 92,352 shares of common stock on 10/21/2025 at a price of $3.005 per share (transaction code S). Following this sale, the reporting person beneficially owns 279,248 shares, held directly. This filing discloses a change in insider holdings and reflects a single reported transaction.
Bio Green Med Solution (BGMS) reported an insider transaction on Form 4. On 10/20/2025, 10% owner Datuk Tan Chor How Christopher sold 108,107 shares of common stock at $3.088 per share (Transaction Code: S). Following the sale, the reporting person beneficially owns 371,600 shares, held directly.
Bio Green Med Solution (BGMS) insider activity: Reporting person Kua Khai Loon, a director, filed a Form 4 disclosing open-market sales of BGMS common stock. On 10/15/2025, 7,479 shares were sold at $5.661, leaving 330,681 shares beneficially owned. On 10/16/2025, 88,204 shares were sold at $4.217, leaving 242,477 shares beneficially owned. Ownership is listed as Direct. The filing was made by one reporting person.
Bio Green Med Solution (BGMS) Form 4: A reporting person identified as a 10% owner reported a sale of common stock. On 10/16/2025, the holder sold 26,051 shares (transaction code S) at a price of $5.50 per share. Following this transaction, the filer beneficially owned 479,707 shares, held directly.